The precise mechanism linking the common MTHFR C677T polymorphism with hypertension and the modulating effect of riboflavin on BP in these genetically at‐risk individuals remains unexplained but is likely to involve the potent vasodilator, nitric oxide (NO).6, 37. Here, MTHFR is linked to hypertensive disorder.